The U.S. Centers for Disease Control and Prevention and Food and Drug Administration have lifted their recommended pause on use of Johnson & Johnson’s Coronavirus Vaccine. The Vaccine’s rollout has been on pause since April 13th, after a small number of people experienced blood clots after taking the shot.
The label will now be updated to warn of blood clot risks. The FDA says vaccinations could resume as soon as Saturday. The CDC did say during Friday’s meeting that other possible cases are under investigation and they also expect more will be reported once vaccinations resume.